Table of Contents Author Guidelines Submit a Manuscript
Canadian Journal of Infectious Diseases and Medical Microbiology
Volume 2016 (2016), Article ID 3076380, 6 pages
http://dx.doi.org/10.1155/2016/3076380
Clinical Study

Human Papilloma Virus Persistence after Cone Excision in Women with Cervical High Grade Squamous Intraepithelial Lesion: A Prospective Study

1Department of Obstetrics and Gynecology, University of Medicine and Pharmacy “Victor Babeş”, Timişoara, 300041 Timiș, Romania
2Department of Anatomy, University of Medicine and Pharmacy “Victor Babeş”, Timişoara, 300041 Timiș, Romania
3Department of Obstetrics and Gynecology, County Hospital Timişoara, 300202 Timiș, Romania
4Department of Informatics and Statistics, University of Medicine and Pharmacy “Victor Babeş”, Timişoara, 300041 Timiș, Romania
5Department of Surgery, University of Medicine and Pharmacy “Victor Babeş”, Timişoara, 300041 Timiș, Romania
6Department of Microbiology, University of Medicine and Pharmacy “Victor Babeş”, Timişoara, Piata Eftimie Murgu, No. 1, 300041 Timiș, Romania

Received 13 February 2016; Revised 14 April 2016; Accepted 20 April 2016

Academic Editor: Bruno Pozzetto

Copyright © 2016 Laurențiu Pirtea et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. M. Walboomers, M. V. Jacobs, M. M. Manos et al., “Human papillomavirus is a necessary cause of invasive cervical cancer worldwide,” The Journal of Pathology, vol. 189, no. 1, pp. 12–19, 1999. View at Google Scholar
  2. E. L. Franco, L. L. Villa, J. P. Sobrinho et al., “Epidemiology of acquisition and clearance of cervical human papillomavirus infection in women from a high-risk area for cervical cancer,” Journal of Infectious Diseases, vol. 180, no. 5, pp. 1415–1423, 1999. View at Publisher · View at Google Scholar · View at Scopus
  3. S. M. Garland, “Can cervical cancer be eradicated by prophylactic HPV vaccination? Challenges to vaccine implementation,” Indian Journal of Medical Research, vol. 130, no. 3, pp. 311–321, 2009. View at Google Scholar · View at Scopus
  4. C. B. J. Woodman, S. I. Collins, and L. S. Young, “The natural history of cervical HPV infection: unresolved issues,” Nature Reviews Cancer, vol. 7, no. 1, pp. 11–22, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. W. A. A. Tjalma, T. R. van Waes, L. E. M. van den Eeden, and J. J. P. M. Bogers, “Role of human papillomavirus in the carcinogenesis of squamos cell carcinoma and adenocarcinoma of the cervix,” Best Practice & Research: Clinical Obstetrics & Gynaecology, vol. 19, no. 4, pp. 469–483, 2005. View at Publisher · View at Google Scholar · View at Scopus
  6. G. Hoste, K. Vossaert, and W. A. Poppe, “The clinical role of HPV testing in primary and secondary cervical cancer screening,” Obstetrics and Gynecology International, vol. 2013, Article ID 610373, 7 pages, 2013. View at Publisher · View at Google Scholar
  7. E. Kucera, G. Sliutz, K. Czerwenka, G. Breitenecker, S. Leodolter, and A. Reinthaller, “Is high-risk human papillomavirus infection associated with cervical intraepithelial neoplasia eliminated after conization by large-loop excision of the transformation zone?” European Journal of Obstetrics & Gynecology and Reproductive Biology, vol. 100, no. 1, pp. 72–76, 2001. View at Publisher · View at Google Scholar · View at Scopus
  8. Y. Nagai, T. Maehama, T. Asato, and K. Kanazawa, “Persistence of human papillomavirus infection after therapeutic conization for CIN 3: is it an alarm for disease recurrence?” Gynecologic Oncology, vol. 79, no. 2, pp. 294–299, 2000. View at Publisher · View at Google Scholar · View at Scopus
  9. E. Paraskevaidis, G. Koliopoulos, Y. Alamanos, V. Malamou-Mitsi, E. D. Lolis, and H. C. Kitchener, “Human papillomavirus testing and the outcome of treatment for cervical intraepithelial neoplasia,” Obstetrics and Gynecology, vol. 98, no. 5, pp. 833–836, 2001. View at Publisher · View at Google Scholar · View at Scopus
  10. K.-L. Chua and A. Hjerpe, “Human papillomavirus analysis as a prognostic marker following conization of the cervix uteri,” Gynecologic Oncology, vol. 66, no. 1, pp. 108–113, 1997. View at Publisher · View at Google Scholar · View at Scopus
  11. Centers for Disease Control and Prevention, “Progress toward implementation of human papillomavirus vaccination—the Americas, 2006–2010,” Morbidity and Mortality Weekly Report, vol. 60, no. 40, pp. 1382–1384, 2011. View at Google Scholar
  12. J. Ferlay, H.-R. Shin, F. Bray, D. Forman, C. Mathers, and D. M. Parkin, “Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008,” International Journal of Cancer, vol. 127, no. 12, pp. 2893–2917, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. J. T. Cox, “Epidemiology of cervical intraepithelial neoplasia: the role of human papillomavirus,” Bailliere's Clinical Obstetrics and Gynaecology, vol. 9, no. 1, pp. 1–37, 1995. View at Publisher · View at Google Scholar · View at Scopus
  14. U. Jaisamrarn, X. Castellsagué, and S. M. Garland, “Natural history of progression of HPV infection to cervical lesion or clearance: analysis of the control arm of the large, randomised PATRICIA study,” PLoS ONE, vol. 8, no. 11, Article ID e79260, 2013. View at Publisher · View at Google Scholar
  15. J. Koshiol, L. Lindsay, J. M. Pimenta, C. Poole, D. Jenkins, and J. S. Smith, “Persistent human papillomavirus infection and cervical neoplasia: a systematic review and meta-analysis,” American Journal of Epidemiology, vol. 168, no. 2, pp. 123–137, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. J. Bodily and L. A. Laimins, “Persistence of human papillomavirus infection: keys to malignant progression,” Trends in Microbiology, vol. 19, no. 1, pp. 33–39, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. P. E. Castle, “Invited commentary: is monitoring of human papillomavirus infection for viral persistence ready for use in cervical cancer screening?” American Journal of Epidemiology, vol. 168, no. 2, pp. 138–144, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. N. Duesing, J. Schwarz, M. Choschzick et al., “Assessment of cervical intraepithelial neoplasia (CIN) with colposcopic biopsy and efficacy of loop electrosurgical excision procedure (LEEP),” Archives of Gynecology and Obstetrics, vol. 286, no. 6, pp. 1549–1554, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. J.-Y. Park, K. H. Lee, S. M. Dong, S. Kang, S.-Y. Park, and S.-S. Seo, “The association of pre-conization high-risk HPV load and the persistence of HPV infection and persistence/recurrence of cervical intraepithelial neoplasia after conization,” Gynecologic Oncology, vol. 108, no. 3, pp. 549–554, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. S. H. Song, J. K. Lee, M. J. Oh et al., “Persistent HPV infection after conization in patients with negative margins,” Gynecologic Oncology, vol. 101, no. 3, pp. 418–422, 2006. View at Publisher · View at Google Scholar
  21. Y. T. Kim, J. M. Lee, S. Y. Hur et al., “Clearance of human papillomavirus infection after successful conization in patients with cervical intraepithelial neoplasia,” International Journal of Cancer, vol. 126, no. 8, pp. 1903–1909, 2010. View at Publisher · View at Google Scholar
  22. K. Nam, S. Chung, J. Kim, S. Jeon, and D. Bae, “Factors associated with HPV persistence after conization in patients with negative margins,” Journal of Gynecologic Oncology, vol. 20, no. 2, pp. 91–95, 2009. View at Publisher · View at Google Scholar
  23. I. Alonso, A. Torné, L. M. Puig-Tintoré et al., “Pre- and post-conization high-risk HPV testing predicts residual/recurrent disease in patients treated for CIN 2-3,” Gynecologic Oncology, vol. 103, no. 2, pp. 631–636, 2006. View at Publisher · View at Google Scholar · View at Scopus
  24. I. Alonso, A. Torné, L. M. Puig-Tintoré et al., “High-risk cervical epithelial neoplasia grade 1 treated by loop electrosurgical excision: follow-up and value of HPV testing,” American Journal of Obstetrics & Gynecology, vol. 197, no. 4, pp. 359.e1–359.e6, 2007. View at Publisher · View at Google Scholar · View at Scopus
  25. J. Verguts, B. Bronselaer, G. Donders et al., “Prediction of recurrence after treatment for high-grade cervical intraepithelial neoplasia: the role of human papillomavirus testing and age at conisation,” BJOG: An International Journal of Obstetrics and Gynaecology, vol. 113, no. 11, pp. 1303–1307, 2006. View at Publisher · View at Google Scholar · View at Scopus
  26. M. Kocken, M. H. Uijterwaal, A. L. M. de Vries et al., “High-risk human papillomavirus testing versus cytology in predicting post-treatment disease in women treated for high-grade cervical disease: a systematic review and meta-analysis,” Gynecologic Oncology, vol. 125, no. 2, pp. 500–507, 2012. View at Publisher · View at Google Scholar · View at Scopus
  27. L. O. Z. Sarian, S. F. M. Derchain, D. D. R. Pitta, S. S. Morais, and S. H. Rabelo-Santos, “Factors associated with HPV persistence after treatment for high-grade cervical intra-epithelial neoplasia with large loop excision of the transformation zone (LLETZ),” Journal of Clinical Virology, vol. 31, no. 4, pp. 270–274, 2004. View at Publisher · View at Google Scholar · View at Scopus
  28. V. Houfflin Debarge, P. Collinet, D. Vinatier et al., “Value of human papillomavirus testing after conization by loop electrosurgical excision for high-grade squamous intraepithelial lesions,” Gynecologic Oncology, vol. 90, no. 3, pp. 587–592, 2003. View at Publisher · View at Google Scholar · View at Scopus
  29. W. D. Kang, M. J. Oh, S. M. Kim, J. H. Nam, C. S. Park, and H. S. Choi, “Significance of human papillomavirus genotyping with high-grade cervical intraepithelial neoplasia treated by a loop electrosurgical excision procedure,” American Journal of Obstetrics and Gynecology, vol. 203, no. 1, pp. 72.e1–72.e6, 2010. View at Publisher · View at Google Scholar · View at Scopus
  30. A. Ryu, K. Nam, J. Kwak, J. Kim, and S. Jeon, “Early human papillomavirus testing predicts residual/recurrent disease after LEEP,” Journal of Gynecologic Oncology, vol. 23, no. 4, pp. 217–225, 2012. View at Publisher · View at Google Scholar
  31. S. Brismar, B. Johansson, M. Borjesson, M. Arbyn, and S. Andersson, “Follow-up after treatment of cervical intraepithelial neoplasia by human papillomavirus genotyping,” American Journal of Obstetrics and Gynecology, vol. 201, no. 1, pp. 17.e1–17.e8, 2009. View at Publisher · View at Google Scholar · View at Scopus
  32. M.-C. Rousseau, J. S. Pereira, J. C. M. Prado, L. L. Villa, T. E. Rohan, and E. L. Franco, “Cervical coinfection with human papillomavirus (HPV) types as a predictor of acquisition and persistence of HPV infection,” Journal of Infectious Diseases, vol. 184, no. 12, pp. 1508–1517, 2001. View at Publisher · View at Google Scholar · View at Scopus
  33. A. K. Chaturvedi, H. A. Katki, A. Hildesheim et al., “Human papillomavirus infection with multiple types: pattern of coinfection and risk of cervical disease,” The Journal of Infectious Diseases, vol. 203, no. 7, pp. 910–920, 2011. View at Publisher · View at Google Scholar
  34. K.-L. Liaw, A. Hildesheim, R. D. Burk et al., “A prospective study of human papillomavirus (HPV) type 16 DNA detection by polymerase chain reaction and its association with acquisition and persistence of other HPV types,” The Journal of Infectious Diseases, vol. 183, no. 1, pp. 8–15, 2001. View at Publisher · View at Google Scholar · View at Scopus